Samuel Meignan

1.3k total citations
34 papers, 901 citations indexed

About

Samuel Meignan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Samuel Meignan has authored 34 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Samuel Meignan's work include Cancer, Hypoxia, and Metabolism (7 papers), Glioma Diagnosis and Treatment (5 papers) and Nerve injury and regeneration (5 papers). Samuel Meignan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Glioma Diagnosis and Treatment (5 papers) and Nerve injury and regeneration (5 papers). Samuel Meignan collaborates with scholars based in France, Japan and Spain. Samuel Meignan's co-authors include Xuefen Le Bourhis, Éric Adriaenssens, Chann Lagadec, Hubert Hondermarck, Elsa Vanhecke, Stéphanie Verbeke, Robert‐Alain Toillon, Emmanuelle Germain, Rodrigue Romon and Éric Lartigau and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Samuel Meignan

33 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Meignan France 15 436 233 170 159 118 34 901
Kerstin Maaser Germany 22 610 1.4× 365 1.6× 211 1.2× 193 1.2× 83 0.7× 29 1.4k
Angela Rigopoulos Australia 17 304 0.7× 297 1.3× 89 0.5× 81 0.5× 62 0.5× 53 1000
H. J. Wester Germany 14 430 1.0× 290 1.2× 137 0.8× 43 0.3× 82 0.7× 27 1.3k
Yanping Yang China 21 454 1.0× 299 1.3× 89 0.5× 70 0.4× 77 0.7× 61 1.1k
Leo G. Flores Japan 17 647 1.5× 290 1.2× 134 0.8× 93 0.6× 37 0.3× 69 1.5k
Trevor Price United States 9 340 0.8× 308 1.3× 140 0.8× 41 0.3× 48 0.4× 21 849
Simone Maschauer Germany 23 596 1.4× 527 2.3× 173 1.0× 348 2.2× 291 2.5× 70 1.5k
Kumiko Koyama Japan 21 767 1.8× 340 1.5× 251 1.5× 104 0.7× 184 1.6× 58 1.6k
Janette Carlsen Germany 18 324 0.7× 241 1.0× 186 1.1× 63 0.4× 18 0.2× 23 1.2k
Michael L. Nickels United States 16 526 1.2× 280 1.2× 369 2.2× 45 0.3× 56 0.5× 36 1.2k

Countries citing papers authored by Samuel Meignan

Since Specialization
Citations

This map shows the geographic impact of Samuel Meignan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Meignan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Meignan more than expected).

Fields of papers citing papers by Samuel Meignan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Meignan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Meignan. The network helps show where Samuel Meignan may publish in the future.

Co-authorship network of co-authors of Samuel Meignan

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Meignan. A scholar is included among the top collaborators of Samuel Meignan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Meignan. Samuel Meignan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bal-Mahieu, Christine, Ángel M. Carcaboso, Xuefen Le Bourhis, et al.. (2021). Evofosfamide Is Effective against Pediatric Aggressive Glioma Cell Lines in Hypoxic Conditions and Potentiates the Effect of Cytotoxic Chemotherapy and Ionizing Radiations. Cancers. 13(8). 1804–1804. 6 indexed citations
2.
Escande, Alexandre, et al.. (2021). Hypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy. Frontiers in Endocrinology. 12. 742215–742215. 69 indexed citations
3.
Bliman, David, et al.. (2018). Enzymatically Activated Glyco-Prodrugs of Doxorubicin Synthesized by a Catalysis-Free Diels–Alder Reaction. Bioconjugate Chemistry. 29(7). 2370–2381. 7 indexed citations
4.
Takayama, Yuki, Momoko Kumemura, Laurent Jalabert, et al.. (2017). A practical single cell analysis method for mechanical characterization of cancer cells. 608–611. 4 indexed citations
5.
Leblond, Pierre, et al.. (2016). Inhibition du récepteur MET : un espoir dans la lutte contre les résistances aux thérapies ciblées ?. Bulletin du Cancer. 104(2). 157–166. 6 indexed citations
6.
Mouawad, F., et al.. (2016). Human epidermal growth factor receptor 3 in head and neck squamous cell carcinomas. Head & Neck. 38(S1). E2412–8. 6 indexed citations
7.
Thibault, Benoît, Emily Clement, Samuel Meignan, et al.. (2015). F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer. Cancer Letters. 370(1). 10–18. 20 indexed citations
8.
Rahier, Nicolas J., Christophe Long, S. K. Deshmukh, et al.. (2015). Anticancer activity of koningic acid and semisynthetic derivatives. Bioorganic & Medicinal Chemistry. 23(13). 3712–3721. 29 indexed citations
9.
Baldeyrou, Brigitte, Christine Bal-Mahieu, Till Bousquet, et al.. (2015). Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors. Bioorganic & Medicinal Chemistry. 24(4). 651–660. 25 indexed citations
10.
Escande, Fabienne, N. Rocourt, Jacques Grill, et al.. (2015). Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma. Annals of Clinical and Translational Neurology. 2(4). 439–443. 47 indexed citations
11.
Leblond, Pierre, Christine Bal-Mahieu, Arnaud Pillon, et al.. (2014). Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines.. Investigational New Drugs. 32(5). 883–892. 12 indexed citations
12.
Leblond, Pierre, Christine Bal-Mahieu, Marc Baroncini, et al.. (2013). Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction. Anti-Cancer Drugs. 24(8). 818–825. 13 indexed citations
13.
Mouawad, F., Christine Bal-Mahieu, Éric Lartigau, et al.. (2013). The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines. Oral Oncology. 50(2). 113–119. 14 indexed citations
14.
Verbeke, Stéphanie, et al.. (2013). Extracellular cleavage of the p75 neurotrophin receptor is implicated in its pro‐survival effect in breast cancer cells. FEBS Letters. 587(16). 2591–2596. 21 indexed citations
15.
Meignan, Samuel, Catherine Foulon, Perrine Six, et al.. (2012). New selective carbonic anhydrase IX inhibitors: Synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides. Bioorganic & Medicinal Chemistry. 21(6). 1451–1464. 59 indexed citations
16.
Vanhecke, Elsa, Éric Adriaenssens, Stéphanie Verbeke, et al.. (2011). Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival. Clinical Cancer Research. 17(7). 1741–1752. 101 indexed citations
17.
Leblond, Pierre, et al.. (2011). L’inhibiteur d’intégrines Cilengitide : un nouveau principe actif en neuro-oncologie. Bulletin du Cancer. 98(9). 1083–1090. 4 indexed citations
18.
Verbeke, Stéphanie, Samuel Meignan, Chann Lagadec, et al.. (2010). Overexpression of p75NTR increases survival of breast cancer cells through p21waf1. Cellular Signalling. 22(12). 1864–1873. 53 indexed citations
19.
Lagadec, Chann, Rodrigue Romon, Samuel Meignan, et al.. (2010). Ku86 is important for TrkA overexpression‐induced breast cancer cell invasion. PROTEOMICS - CLINICAL APPLICATIONS. 4(6-7). 580–590. 14 indexed citations
20.
Lagadec, Chann, Samuel Meignan, Éric Adriaenssens, et al.. (2009). TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene. 28(18). 1960–1970. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerstin Maaser Breakdown of academic impact, for papers by Angela Rigopoulos Breakdown of academic impact, for papers by H. J. Wester Breakdown of academic impact, for papers by Yanping Yang Breakdown of academic impact, for papers by Leo G. Flores Breakdown of academic impact, for papers by Trevor Price Breakdown of academic impact, for papers by Simone Maschauer Breakdown of academic impact, for papers by Kumiko Koyama Breakdown of academic impact, for papers by Janette Carlsen Breakdown of academic impact, for papers by Michael L. Nickels
Rankless by CCL
2026